ArticleCell death & disease2023

METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.

Chengjie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.